BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32601196)

  • 21. Muscleblind-like 1 activates insulin receptor exon 11 inclusion by enhancing U2AF65 binding and splicing of the upstream intron.
    Echeverria GV; Cooper TA
    Nucleic Acids Res; 2014 Feb; 42(3):1893-903. PubMed ID: 24185704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation.
    Choi J; Personius KE; DiFranco M; Dansithong W; Yu C; Srivastava S; Dixon DM; Bhatt DB; Comai L; Vergara JL; Reddy S
    EBioMedicine; 2015 Sep; 2(9):1034-47. PubMed ID: 26501102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
    Otto KB; Acharya SS; Robinson VL
    Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscleblind-like 1 (Mbnl1) regulates pre-mRNA alternative splicing during terminal erythropoiesis.
    Cheng AW; Shi J; Wong P; Luo KL; Trepman P; Wang ET; Choi H; Burge CB; Lodish HF
    Blood; 2014 Jul; 124(4):598-610. PubMed ID: 24869935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct signaling properties of mitogen-activated protein kinase kinases 4 (MKK4) and 7 (MKK7) in embryonic stem cell (ESC) differentiation.
    Wang J; Chen L; Ko CI; Zhang L; Puga A; Xia Y
    J Biol Chem; 2012 Jan; 287(4):2787-97. PubMed ID: 22130668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins.
    Wang ET; Ward AJ; Cherone JM; Giudice J; Wang TT; Treacy DJ; Lambert NJ; Freese P; Saxena T; Cooper TA; Burge CB
    Genome Res; 2015 Jun; 25(6):858-71. PubMed ID: 25883322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer.
    Sen S; Talukdar I; Liu Y; Tam J; Reddy S; Webster NJ
    J Biol Chem; 2010 Aug; 285(33):25426-37. PubMed ID: 20519504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ubiquitination of MBNL1 Is Required for Its Cytoplasmic Localization and Function in Promoting Neurite Outgrowth.
    Wang PY; Chang KT; Lin YM; Kuo TY; Wang GS
    Cell Rep; 2018 Feb; 22(9):2294-2306. PubMed ID: 29490267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Rac1/MKK7/JNK pathway signals upregulation of Atg5 and subsequent autophagic cell death in response to oncogenic Ras.
    Byun JY; Yoon CH; An S; Park IC; Kang CM; Kim MJ; Lee SJ
    Carcinogenesis; 2009 Nov; 30(11):1880-8. PubMed ID: 19783847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex.
    Paul S; Dansithong W; Jog SP; Holt I; Mittal S; Brook JD; Morris GE; Comai L; Reddy S
    J Biol Chem; 2011 Nov; 286(44):38427-38438. PubMed ID: 21900255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
    Lin X; Miller JW; Mankodi A; Kanadia RN; Yuan Y; Moxley RT; Swanson MS; Thornton CA
    Hum Mol Genet; 2006 Jul; 15(13):2087-97. PubMed ID: 16717059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct contributions of JNK and p38 to chromium cytotoxicity and inhibition of murine embryonic stem cell differentiation.
    Chen L; Ovesen JL; Puga A; Xia Y
    Environ Health Perspect; 2009 Jul; 117(7):1124-30. PubMed ID: 19654923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA splicing is responsive to MBNL1 dose.
    Jog SP; Paul S; Dansithong W; Tring S; Comai L; Reddy S
    PLoS One; 2012; 7(11):e48825. PubMed ID: 23166594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of T regulatory cell suppression following signaling through glucocorticoid-induced tumor necrosis receptor (GITR) is dependent on c-Jun N-terminal kinase activation.
    Joetham A; Ohnishi H; Okamoto M; Takeda K; Schedel M; Domenico J; Dakhama A; Gelfand EW
    J Biol Chem; 2012 May; 287(21):17100-17108. PubMed ID: 22461627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoregulation of MBNL1 function by exon 1 exclusion from MBNL1 transcript.
    Konieczny P; Stepniak-Konieczna E; Taylor K; Sznajder LJ; Sobczak K
    Nucleic Acids Res; 2017 Feb; 45(4):1760-1775. PubMed ID: 27903900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MBNL1 overexpression is not sufficient to rescue the phenotypes in a mouse model of RNA toxicity.
    Yadava RS; Kim YK; Mandal M; Mahadevan K; Gladman JT; Yu Q; Mahadevan MS
    Hum Mol Genet; 2019 Jul; 28(14):2330-2338. PubMed ID: 30997488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of MBNL1 and MBNL3 domains required for splicing activation and repression.
    Grammatikakis I; Goo YH; Echeverria GV; Cooper TA
    Nucleic Acids Res; 2011 Apr; 39(7):2769-80. PubMed ID: 21109529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissecting domains necessary for activation and repression of splicing by Muscleblind-like protein 1.
    Edge C; Gooding C; Smith CW
    BMC Mol Biol; 2013 Dec; 14():29. PubMed ID: 24373687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired JNK signaling cooperates with KrasG12D expression to accelerate pancreatic ductal adenocarcinoma.
    Davies CC; Harvey E; McMahon RF; Finegan KG; Connor F; Davis RJ; Tuveson DA; Tournier C
    Cancer Res; 2014 Jun; 74(12):3344-56. PubMed ID: 24713432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing.
    Goers ES; Purcell J; Voelker RB; Gates DP; Berglund JA
    Nucleic Acids Res; 2010 Apr; 38(7):2467-84. PubMed ID: 20071745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.